Dasami Lab

Chityal, India Founded: 2015 • Age: 11 yrs
A pharmaceutical company focused on developing and manufacturing active pharmaceutical ingredients and other products.

About Dasami Lab

Dasami Lab is a Healthcare company based in Chityal (India) founded in 2015. It operates as an a pharmaceutical company focused on developing and manufacturing active pharmaceutical ingredients and other products. It operates on a B2B model. The company has 427 employees. Its Indian entity Dasami Lab Private Limited reported revenue of β‚Ή694 Cr. Its focus areas include Pharmaceuticals, API Manufacturing and Drug Development.

Company details

Dasami Lab operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, api manufacturing, and drug development. A pharmaceutical company focused on developing and manufacturing active pharmaceutical ingredients and other products. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

Key Metrics
  • Annual Revenue
    ₹694 Cr

    FY 2025 · +22% YoY

  • Net Profit
    ₹55.11 Cr

    FY 2025 · 8% margin

  • EBITDA
    ₹114 Cr

    FY 2025 · 16% margin

  • Employee Count
    427

Board of directors of Dasami Lab Private Limited (Dasami Lab)

Dasami Lab Private Limited is the primary company behind Dasami Lab. The board of Dasami Lab Private Limited currently have 2 directors; the longest-serving is Mohana Reddy Chilukuri, appointed in 2015. 7 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Mohana Reddy Chilukuri
DIN 00208921
Director24 Jul 201511 yrs 2 moDasami Lab Private Limited
Krishnaveni Kura
DIN 07033330
Director24 Jul 20179 yrs 2 moDasami Lab Private Limited

Financials of Dasami Lab

Figures of Dasami Lab Private Limited, the primary company behind Dasami Lab, for FY 2025. Revenue was ₹694 Cr (+22% year on year). Net profit was ₹55.11 Cr (8% margin). EBITDA was ₹114 Cr (16% margin). Revenue has grown at a compounded annual rate of +22% over three years and +34% over five years.

  • ₹694 CrRevenue · FY 2025 · +22% YoY
  • ₹55.11 CrNet profit · 8% margin
  • ₹114 CrEBITDA · 16% margin
  • ₹70.00 CrPaid-up capital
  • 427Employees (provident fund records)
  • +22%Revenue CAGR, 3 years
  • +34%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Dasami Lab Private Limited are on its company page.

Premium access

Detailed financial statements for Dasami Lab

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Top companies in Pharmaceuticals & Distribution

10 companies that operate in the same segment as Dasami Lab (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 213.52 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Dasami Lab

Dasami Lab was founded in 2015.

Dasami Lab is headquartered in Chityal, India. It is registered at Chityal, Telangana, India.

Dasami Lab has 427 employees.

The primary company behind Dasami Lab, Dasami Lab Private Limited, reported revenue of β‚Ή694 Cr for FY 2025, up 22% year on year.

Dasami Lab operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, api manufacturing, and drug development. A pharmaceutical company focused on developing and manufacturing active pharmaceutical ingredients and other products. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

Dasami Lab operates through Dasami Lab Private Limited.

The legal entities of Dasami Lab currently have 3 directors, including Krishnaveni Kura, Mohana Reddy Chilukuri, Sanjaya Kumar Pradhan.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available